World Library  
Flag as Inappropriate
Email this Article

Tegafur/gimeracil/oteracil

Article Id: WHEBN0040788819
Reproduction Date:

Title: Tegafur/gimeracil/oteracil  
Author: World Heritage Encyclopedia
Language: English
Subject: Tegafur, Chemotherapy, Cell-cycle nonspecific antineoplastic agents, Hazardous drugs, Thiopurine
Collection: Combination Drugs, Pyrimidine Antagonists
Publisher: World Heritage Encyclopedia
Publication
Date:
 

Tegafur/gimeracil/oteracil

Tegafur/gimeracil/oteracil
Combination of
Tegafur Antineoplastic drug
Gimeracil Enzyme inhibitor
Oteracil Enzyme inhibitor
Clinical data
Trade names Teysuno
AHFS/Drugs.com
Licence data EMA:
Pregnancy
category
  • Contraindicated
Legal status
Routes of
administration
Oral
Identifiers
CAS Registry Number
ATC code L01
PubChem CID:

The combination drug tegafur/gimeracil/oteracil (trade name Teysuno, and TS-1 in Japan[1]) is used for the treatment of advanced gastric cancer.[2] It is also being developed for the treatment of hepatocellular carcinoma.[3]

Mechanism of action

Tegafur is the actual chemotherapeutic agent. It is a prodrug of the active substance fluorouracil (5-FU).

Gimeracil inhibits the degradation of fluorouracil by reversibly blocking a dehydrogenase enzyme. This results in higher 5-FU levels and a prolonged half-life of the substance.

Oteracil mainly stays in the gut because of its low permeability, where it reduces the production of 5-FU by blocking the enzyme orotate phosphoribosyltransferase. Lower 5-FU levels in the gut result in a lower gastrointestinal toxicity.[4]

This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and USA.gov, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for USA.gov and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
 
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
 
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.
 


Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.